201 – 210 of 335
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Genetic aspects and research development in haemostasis
- Contribution to journal › Article
-
Mark
Genetic aspects of inhibitor development
(2008) XXVIIIth International Congress of the World Federation of Hemophilia, 2008 In Haemophilia 14(s2). p.21-21
- Contribution to journal › Published meeting abstract
-
Mark
Thrombin generation assay: a useful tool in the management of haemophilia A patients?
(2008) XXVIIIth International Congress of the World Federation of Hemophilia, 2008 In Haemophilia 14(s2). p.26-26
- Contribution to journal › Published meeting abstract
-
Mark
Prophylaxis in von Willebrand disease.
- Contribution to journal › Article
-
Mark
Protecting the joints of mice and men.
- Contribution to journal › Article
-
Mark
Cost and outcome: comparisons of two alternative bypassing agents for persons with haemophilia A complicated by an inhibitor.
- Contribution to journal › Article
-
Mark
Standardization and clinical utility of thrombin-generation assays.
- Contribution to journal › Article
-
Mark
Effects of pentoxifylline and its metabolites on platelet aggregation in whole blood from healthy humans.
- Contribution to journal › Article
-
Mark
VWD type 3 - historical review and contemporary treatment dilemmas
(2008) XXVIIIth International Congress of the World Federation of Hemophilia, 2008 In Haemophilia 14(s2). p.111-111
- Contribution to journal › Published meeting abstract
-
Mark
Value added: increasing the power to assess treatment outcome in joint haemorrhages
- Contribution to journal › Article
